Skip to main content
Equibles
SCNX logo

SCNX · Scienture Holdings, Inc.

Track SCNX — free

Use SCNX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.37 +0.00 (+0.82%) At close · Sep 2
Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing states the doubt was alleviated.

“While these conditions initially indicated substantial doubt about the Company's ability to continue as a going concern, management believes that its plans described above alleviate that doubt for at least one year after the date these condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 13, 2026
Market Cap
$15.07M
Shares
41.06M

SCNX metrics

61 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.37
Market cap
$15.07M

Price action

19 metrics
Price change (1W)
-11.2%
Price change (30D)
-5.2%
Price change (3M)
-6.1%
Price change (6M)
-6.9%
Price change (YTD)
-28.0%
Price change (1Y)
-62.4%
Trailing year
Price change (5Y)
—
52-week high
$2.60
52-week low
$0.24
Change from 52-week high
-85.9%
Change from 52-week low
+52.3%
Annualized volatility
371.2%
Beta
2.7
RSI (14D)
39.0
Price vs SMA 50
-6.4%
Price vs SMA 200
-16.4%
Avg volume (3M)
2.48M
Relative volume
0.2
Average dollar volume
$996,821

Company

3 metrics
Sector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
41.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
18.3×
reciprocal yield 5.4%
P / book
0.2
reciprocal yield 425.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-251.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
4.8×
reciprocal yield 20.7%
EV / revenue historical average (5Y)
4.8×
reciprocal yield 20.7%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
98.6%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2024-07-19

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-20

Profitability

9 metrics
Gross margin
76.8%
Operating margin
-9,867.9%
Trailing 12 months
Net margin
-9,618.0%
Gross profit (TTM)
—
Operating profit (TTM)
−$40.07M
Net income (TTM)
−$37.95M
Trailing 12 months
Diluted EPS (TTM)
$-2.04
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.09

Growth

11 metrics
Revenue growth YoY
+215.9%
Year over year
Net income growth YoY
-557.9%
Revenue (TTM)
$821,315
Trailing 12 months
EPS growth YoY
-208.9%
Shares change YoY
+180.1%
Year over year · more shares
Revenue CAGR (3Y)
-65.2%
Revenue CAGR (5Y)
-52.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-59.2%
Return on assets
-43.3%
Debt / equity
—
Current ratio
3.0
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.0
Interest coverage
-13.1
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$8.19M
Total assets
$87.73M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$14.44M
Capital expenditures (TTM)
—
R&D (TTM)
$2.50M
SG&A (TTM)
—
Stock compensation (TTM)
$2.11M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
16
13F filer change QoQ
+2
Institutional ownership
4.9%

Short interest

3 metrics
Short interest
3.9%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1382574 CUSIP 80880X104 13F (30d) 13 filings 13 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)